844 related articles for article (PubMed ID: 25606362)
21. Hyperexcitability in the olfactory bulb and impaired fine odor discrimination in the
Kuruppath P; Xue L; Pouille F; Jones ST; Schoppa NE
bioRxiv; 2023 Apr; ():. PubMed ID: 37090519
[TBL] [Abstract][Full Text] [Related]
22. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
[TBL] [Abstract][Full Text] [Related]
23. Comparative Behavioral Phenotypes of
Saré RM; Figueroa C; Lemons A; Loutaev I; Beebe Smith C
Brain Sci; 2019 Jan; 9(1):. PubMed ID: 30654445
[TBL] [Abstract][Full Text] [Related]
24. FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.
Roth M; Ronco L; Cadavid D; Durbin-Johnson B; Hagerman RJ; Tassone F
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679478
[TBL] [Abstract][Full Text] [Related]
25. Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome.
Randol JL; Kim K; Ponzini MD; Tassone F; Falcon AK; Hagerman RJ; Hagerman PJ
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540415
[TBL] [Abstract][Full Text] [Related]
26. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
[TBL] [Abstract][Full Text] [Related]
27. Anxiety, hyperactivity and stereotypy in a zebrafish model of fragile X syndrome and autism spectrum disorder.
Kim L; He L; Maaswinkel H; Zhu L; Sirotkin H; Weng W
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Dec; 55():40-9. PubMed ID: 24681195
[TBL] [Abstract][Full Text] [Related]
28. Modelling fragile X syndrome in the laboratory setting: A behavioral perspective.
Melancia F; Trezza V
Behav Brain Res; 2018 Sep; 350():149-163. PubMed ID: 29704597
[TBL] [Abstract][Full Text] [Related]
29. A Genotype-Phenotype Study of High-Resolution
Budimirovic DB; Schlageter A; Filipovic-Sadic S; Protic DD; Bram E; Mahone EM; Nicholson K; Culp K; Javanmardi K; Kemppainen J; Hadd A; Sharp K; Adayev T; LaFauci G; Dobkin C; Zhou L; Brown WT; Berry-Kravis E; Kaufmann WE; Latham GJ
Brain Sci; 2020 Sep; 10(10):. PubMed ID: 33008014
[TBL] [Abstract][Full Text] [Related]
30. Fragile X: leading the way for targeted treatments in autism.
Wang LW; Berry-Kravis E; Hagerman RJ
Neurotherapeutics; 2010 Jul; 7(3):264-74. PubMed ID: 20643379
[TBL] [Abstract][Full Text] [Related]
31. Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
Ruby K; Falvey K; Kulesza RJ
Neuroscience; 2015 Sep; 303():285-98. PubMed ID: 26166728
[TBL] [Abstract][Full Text] [Related]
32. A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.
Holley AJ; Shedd A; Boggs A; Lovelace J; Erickson C; Gross C; Jankovic M; Razak K; Huber K; Gibson JR
Neurobiol Dis; 2022 Aug; 170():105767. PubMed ID: 35588990
[TBL] [Abstract][Full Text] [Related]
33. Fragile X spectrum disorders.
Lozano R; Rosero CA; Hagerman RJ
Intractable Rare Dis Res; 2014 Nov; 3(4):134-46. PubMed ID: 25606363
[TBL] [Abstract][Full Text] [Related]
34. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
[TBL] [Abstract][Full Text] [Related]
35. BDNF in fragile X syndrome.
Castrén ML; Castrén E
Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
[TBL] [Abstract][Full Text] [Related]
36. Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
Spencer CM; Alekseyenko O; Serysheva E; Yuva-Paylor LA; Paylor R
Genes Brain Behav; 2005 Oct; 4(7):420-30. PubMed ID: 16176388
[TBL] [Abstract][Full Text] [Related]
37. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome.
Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR
Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501
[TBL] [Abstract][Full Text] [Related]
38. Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats.
Golden CEM; Breen MS; Koro L; Sonar S; Niblo K; Browne A; Burlant N; Di Marino D; De Rubeis S; Baxter MG; Buxbaum JD; Harony-Nicolas H
Cereb Cortex; 2019 May; 29(5):2228-2244. PubMed ID: 30877790
[TBL] [Abstract][Full Text] [Related]
39. Role of FMRP in AKT/mTOR pathway-mediated hippocampal autophagy in fragile X syndrome.
Zhang B; Zhang J; Chen H; Qiao D; Guo F; Hu X; Qin C; Jin X; Zhang K; Wang C; Cui H; Li S
Prog Neuropsychopharmacol Biol Psychiatry; 2024 May; 134():111036. PubMed ID: 38823765
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling.
Gerhardt J
Brain Res; 2017 Feb; 1656():55-62. PubMed ID: 26475977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
